DRUG SUSCEPTIBILITY MYCOBACTERIA WITH TEST SYSTEMS «SENSITITRE»
Abstract
Timely administration of appropriate treatment reduces the level and rate of emergence of resistant strains of mycobacteria. Therefore, the actual is to develop methods for early and reliable drug susceptibility testing. With the help of test systems Sensititre MycoTB
studied 149 strains of M. tuberculosis, isolated from respiratory material patients with chronic forms of tuberculosis. With the help of test systems Sensititre SLOMyco RAPMyco were tested 471 NTMB strain isolated from patients with suspected tuberculosis or mycobacteriosis belonging to species: MAC – 139, M. kansasii – 57, M. xenopi – 59, M. fortuitum group – 170 and M. chelonae group – 46.
The results allowed to conclude that the test system Sensititre have advantages associated with the standardization process and to determine the extent susceptibility/resistant isolates of mycobacteria, as well as the possibility of obtaining information about the spectrum of drug sensitivity to a large number of drugs in the short term.
About the Authors
M. V. Makarova
ГКУЗ «Московский городской научно-практический центр борьбы с туберкулёзом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
Yu. D. Isaeva
ГКУЗ «Московский городской научно-практический центр борьбы с туберкулёзом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
E. N. Hachaturyants
ГКУЗ «Московский городской научно-практический центр борьбы с туберкулёзом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
V. I. Litvinov
ГКУЗ «Московский городской научно-практический центр борьбы с туберкулёзом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
References
1. Дорожкова И.Р. Лекарственная чувствительность микобактерий туберкулеза. Методы определения. Оценка результатов //Лабораторные исследования при туберкулезе. – М., 2013. – 343 с.
2. Литвинов В.И., Макарова М.В., Краснова М.А. Нетуберкулезные микобактерии. – М.: ЗАО «Информационные технологии в медицине», 2008. – 254 с.
3. Abuali M. M., Katariwala R., LaBombardi V.J. A comparison of the Sensititre® MYCOTB panel and the agar proportion method for the susceptibility testing of Mycobacterium tuberculosis // Eur. J. Clin. Microbiol. Infect. Dis. – 2011. – Vol. 31. – P. 835–839.
4. Brown B.A., Wallace R.J., Jr., Onyi G.O. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system // Antimicrob. Agents Chemother. – 1992. – Vol. 36. – P. 1987–1990.
5. Campbell P.J., Morlock G.P., Sikes R.D. et al. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of mycobacterium tuberculosis //Antimicrob. Agents Chemother. – 2011. – Vol. 55. – P. 2032–2041.
6. Centers for Disease Control and Prevention (CDC). Molecular Detection of Drug Resistance (MDDR) (http://www.cdc.gov/tb/topic/laboratory/ UserGuide) доступ 14.07.2007.
7. CLSI. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard – 2nd ed. // CLSI document M24-A2. Clinical and Laboratory Standards Institute. – 2011. (http://www.techstreet.com/ products/ 1779589) доступ 10.12.2013.
8. Hall L., Jude K. P., Clark S.L. et al. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtitre plate format // J. Vis. Exp. – 2011. – Jun. 24 ; (52). Pii: 3094. doi: 10.3791/3094.
9. Heifets L: Qualitative and quantitative drug-susceptibility tests in mycobacteriology // Am. Rev. Respir. Dis. – 1998, – Vol. 137. – P. 1217–1222.
10. Griffith D., Aksamit T., Brown-Elliott B.et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculousis mycobacterial diseases // Am. J. Respir. Crit. Care Med. – 2007. – Vol. 175. – P. 367-416.
11. Mpagama S., Houpt E., Stroup S. et al. Application of quantitative second-line drug susceptibility at a multidrug-resistant tuberculosis hospital in Tanzania // BMC Infectious Diseases. – 2013. – Vol. 13. – 432.
12. Rusch-Gerdes S., Pfyffer G., Casal M. et al. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials // J. Clin. Microbiol. – 2006. – Vol. 44. – P. 6886-6892.
13. Thomson R. Changing epidemiology of pulmonarary nontuberculous mycobacteria infections // Emerg. Infect. Dis. – 2010. – Vol. 16. – P.1576-1583.
14. Wallace R., Glassroth J., Griffith D. et al. Diagnosis and treatment of disease caused by nontuberculous mycobacteria (American Thoracic Society Statement) // Am. J. Respir. Crit. Care Med. – 1997. – Vol 156. – P. 1-25.
15. Woods, G. L., Bergmann J. S., Witebsky F. G. et al Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. //J. Clin. Microbiol. – 1999. – Vol. 37. – P.1676-1682.
16. World Health Organization. Global Tuberculosis Control // WHO, 2010: Geneva, Switzerland. (http://www.who.int/bulletin/volumes/89/8/11-086801) доступ 10.12.2013.
Review
For citations:
Makarova M.V., Isaeva Yu.D., Hachaturyants E.N., Litvinov V.I. DRUG SUSCEPTIBILITY MYCOBACTERIA WITH TEST SYSTEMS «SENSITITRE». Tuberculosis and socially significant diseases. 2013;(2):30-34. (In Russ.)
Views:
27
Email this article 